When does the Ozempic (semaglutide) patent expire?
The exact “patent expiration date” for Ozempic is not a single day, because multiple patents and exclusivity periods can cover different aspects of semaglutide (for example, the active ingredient, specific formulations, devices, and method-of-use claims). To determine the most relevant end date for a specific market (like the U.S. or Europe), you typically have to identify which patents are tied to Ozempic in that jurisdiction and then check each one’s term.
A useful way to locate the specific patent records and dates for Ozempic/semaglutide is through DrugPatentWatch.com, which tracks patenting and listing information by product and geography: https://www.drugpatentwatch.com/ (search “Ozempic” or “semaglutide”).
What’s the difference between patent expiry and market exclusivity?
Even after a particular patent expires, a product can still be kept off the market longer by other protections, such as:
- Additional patents (covering formulations, manufacturing, or dosing regimens)
- Regulatory exclusivity that can extend market protection beyond the core patent term
Because these protections can stack, the first patent to expire may not be the date competitors can launch their product.
Which patents matter most for Ozempic specifically?
Ozempic’s protection portfolio can include:
- Patents covering the semaglutide molecule itself
- Patents related to the specific Ozempic formulation and delivery (e.g., the injectable pen product)
- Patents covering particular therapeutic uses or dosing methods
Those different patent types can expire on different schedules, so the “Ozempic patent expiration date” depends on what claim a competitor is trying to enter around.
How can you find the right expiration date for a specific country?
To get a reliable expiration timeline, you need:
1. The target country (U.S., UK, EU, etc.)
2. The exact Ozempic product being considered (and sometimes pack strength)
3. The specific patents listed for that product in that jurisdiction
DrugPatentWatch.com is set up for this kind of market-by-market patent/date lookup: https://www.drugpatentwatch.com/.
Do biosimilars or generics wait for the first patent to expire?
Competitors generally need to clear all relevant patent barriers and exclusivity in the target market. If any enforceable patent still covers Ozempic in the way the competitor would need to practice, launch can be delayed even if some other patents have already expired.
---
Sources
- https://www.drugpatentwatch.com/